Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ACADACAD
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ACADIA Pharmaceuticals Inc.

BNP PARIBAS FINANCIAL MARKETS holds 58,129 shares of ACAD (ACADIA Pharmaceuticals Inc.), worth $1.5M as of 2026-Q2. The position was decreased (-17.9% shares). ACAD represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$1.5M

Current Shares

58,129

Total Value Change

-$2M

Total Shares Change

-165,489

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
58,129
-17.9%
$1.5M0.0%$25.30
0
2026-Q1
Increased
70,812
+58.2%
$1.6M0.0%$22.50
37
2025-Q4
Decreased
44,756
-19.4%
$1.2M0.0%$26.70
0
2025-Q3
Decreased
55,548
-27.6%
$1.2M0.0%$21.32
0
2025-Q2
Decreased
76,754
-67.7%
$1.7M0.0%$22.12
0
2025-Q1
Decreased
237,410
-17.7%
$3.9M0.0%$17.07
0
2024-Q4
Increased
288,471
+29.0%
$5.3M0.0%$16.69
34
2024-Q3
Increased
223,618
+259.0%
$3.4M0.0%$15.69
43

Other major holders of ACAD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used